My data took Revlimid a number of years ago and had a bad reaction. So he had to stop. His multiple myeloma came under control with the help of daratumumab. Last year (2020) his M Spike was slowly increasing each month. We expected him to have less of a risk of a reaction this subsequent time of taking Revlimid. Unfortunately after a couple of weeks he developed a rash again. Not as bad as the first time. Had to stop Revlimid. Fortunately his M Spike is lower and stable now.
Has anyone else had this pattern? What did you and your prescribers end up deciding to do?